4.7 Article

The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals

Journal

ANTIVIRAL RESEARCH
Volume 149, Issue -, Pages 211-220

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.antiviral.2017.11.015

Keywords

Hepatitis B virus; HBV; HBV core antigen; HBc; HBc structure; HBc phosphorylations; PLK1; Core allosteric modulators; CAMs

Funding

  1. NIH [DK044533-19]
  2. French Embassy in Washington DC
  3. ANRS (French national agency for research on AIDS and viral hepatitis)
  4. ANRS (CSS4)
  5. INSERM
  6. DEVweCAN LABEX of the Universite de Lyon [ANR-10-LABX-0061, ANR-11-IDEX-0007]
  7. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044533] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Virally encoded proteins have evolved to perform multiple functions, and the core protein (HBc) of the hepatitis B virus (HBV) is a perfect example. While HBc is the structural component of the viral nucleocapsid, additional novel functions for the nucleus-localized HBc have recently been described. These results extend for HBc, beyond its structural role, a regulatory function in the viral life cycle and potentially a role in pathogenesis. In this article, we review the diverse roles of HBc in HBV replication and pathogenesis, emphasizing how the unique structure of this protein is key to its various functions. We focus in particular on recent advances in understanding the significance of HBc phosphorylations, its interaction with host proteins and the role of HBc in regulating the transcription of host genes. We also briefly allude to the emerging niche for new direct-acting antivirals targeting HBc, known as Core (protein) Allosteric Modulators (CAMs).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection

Harry L. A. Janssen, Jinlin Hou, Tarik Asselah, Henry L. Y. Chan, Fabien Zoulim, Yasuhito Tanaka, Ewa Janczewska, Ronald G. Nahass, Stefan Bourgeois, Maria Buti, Pietro Lampertico, Oliver Lenz, Thierry Verbinnen, Joris Vandenbossche, Willem Talloen, Ronald Kalmeijer, Maria Beumont, Michael Biermer, Umesh Shukla

Summary: The study evaluated the efficacy and safety of JNJ-56136379 in patients with chronic hepatitis B. The results showed that JNJ-56136379+NA significantly reduced HBV DNA and HBV RNA levels, but had limited effects on HBsAg or HBeAg declines in HBeAg-positive patients. Overall, JNJ-56136379 did not demonstrate clear superiority over NA in terms of efficacy.
Article Gastroenterology & Hepatology

Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure

Lena Allweiss, Barbara Testoni, Mei Yu, Julie Lucifora, Chunkyu Ko, Bingqian Qu, Marc Luetgehetmann, Haitao Guo, Stephan Urban, Simon P. Fletcher, Ulrike Protzer, Massimo Levrero, Fabien Zoulim, Maura Dandri

Summary: A major goal of hepatitis B virus (HBV) treatments is to reduce or inactivate intrahepatic viral covalently closed circular DNA (cccDNA). There are different methods for cccDNA quantification, such as Southern blot (SB) and quantitative PCR (qPCR). This study compared various protocols for cccDNA isolation and qPCR quantification in liver tissues and cell cultures, aiming to develop evidence-based guidance for best practices.
Editorial Material Gastroenterology & Hepatology

Eliminating cccDNA to cure hepatitis B virus infection

Fabien Zoulim, Barbara Testoni

JOURNAL OF HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

EGF receptor modulates HEV entry in human hepatocytes

Jil A. Schrader, Thomas L. Burkard, Yannick Brueggemann, Andre Goemer, Toni L. Meister, Rebecca M. Fu, Ann-Kathrin Mehnert, Viet L. Dao Thi, Patrick Behrendt, David Durantel, Ruth Broering, Florian W. R. Vondran, Daniel Todt, Volker Kinast, Eike Steinmann

Summary: This study identified the EGF receptor (EGFR) as a novel host factor for HEV and revealed the significance of EGFR for the HEV entry process. It was found that EGFR itself and its ligand-binding domain, rather than its signaling function, is responsible for the proviral effect. These findings provide new insights into the life cycle of HEV and identify EGFR as a potential target for future antiviral strategies against HEV.

HEPATOLOGY (2023)

Article Virology

Improved hepatitis delta virus genome characterization by single molecule full-length genome sequencing combined with VIRiONT pipeline

Caroline Charre, Hadrien Regue, Paul Deny, Laurence Josset, Isabelle Chemin, Fabien Zoulim, Caroline Scholtes

Summary: This study presents a workflow to amplify, sequence, and analyze the whole HDV genome in a single fragment. The HDV genome was successfully amplified and fully sequenced, allowing accurate subtyping and identification of a new HDV genotype 1 subtype. This workflow overcomes genome assembly issues and helps to identify modifications throughout the whole HDV genome.

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Gastroenterology & Hepatology

Dynamic personalized prediction of the individual liver-related risk after sustained viral response in HCV patients

Clemence Moreau, Marine Roux, Jeremie Riou, Clemence M. Canivet, Etienne Audureau, Clovis Lusivika-Nzinga, Pierre Nahon, Fabrice Carrat, Jerome Boursier

Summary: This study aimed to evaluate whether the dynamics of multiple measurements of simple parameters after sustained viral response (SVR) enable the development of a personalized prediction of prognosis in patients with hepatitis C virus (HCV) chronic infection. The study found that FIB4 was a biomarker associated with liver-related complications (LRC) occurrence after SVR. The results suggest that dynamic modeling using repeated measurements of simple parameters predicts the individual residual risk of LRC and improves personalized medicine after SVR in HCV patients.

JOURNAL OF VIRAL HEPATITIS (2023)

Article Gastroenterology & Hepatology

Emerging anti-HDV drugs and HBV cure strategies with anti-HDV activity

Armando A. Roca A. Suarez, Enkhtuul Batbold, Birke Bartosch, Naranjargal Dashdorj, Barbara Testoni, Fabien Zoulim

Summary: Hepatitis delta virus (HDV) is a satellite RNA virus that requires hepatitis B virus (HBV) for replication. Co-infection with HDV/HBV leads to faster disease progression compared to HBV mono-infection. Developing antiviral therapies targeting HDV is crucial. Evaluating promising HDV-specific drugs and combination therapies, as well as exploring anti-HBV drugs with potential effects against HDV, are key areas of research.

LIVER INTERNATIONAL (2023)

Article Gastroenterology & Hepatology

Hepatitis C virus replication requires integrity of mitochondria-associated ER membranes

Sarah Duponchel, Lea Monnier, Jennifer Molle, Nadia Bendridi, Muhammad Rizwan Alam, Ahmed Gaballah, Boyan Grigorov, Alexander Ivanov, Marcel Schmiel, Margarete Odenthal, Michel Ovize, Jennifer Rieusset, Fabien Zoulim, Birke Bartosch

Summary: Chronic HCV infection causes cellular stress, fibrosis, and predisposes to hepatocarcinogenesis. Mitochondria play key roles in orchestrating stress responses. The study revealed that HCV proteins associate with mitochondria and alter the composition of mitochondrial subdomains, which are crucial for efficient viral replication.

JHEP REPORTS (2023)

Letter Gastroenterology & Hepatology

Substance use and CD4/CD8 ratio in HIV/HCV co-infected people receiving direct-acting antiviral treatment (ANRS CO13 HEPAVIH)

Tangui Barre, David Zucman, Fabienne Marcellin, Clemence Ramier, Camelia Protopopescu, Raphaelle Tardieu, Karine Ory, Dominique Salmon-Ceron, Patrizia Carrieri

JOURNAL OF VIRAL HEPATITIS (2023)

Review Gastroenterology & Hepatology

Axon guidance molecules in liver pathology: Journeys on a damaged passport

Ievgeniia Chicherova, Charlotte Hernandez, Fanny Mann, Fabien Zoulim, Romain Parent

Summary: The liver is a neurovascular organ that develops various chronic liver diseases (CLD). Axon guidance cues (AGCs) play a role in the physiological development of the nervous system, but their expression can also be reinduced in diseases such as CLD. This review discusses the impact of AGCs on fibrosis regulation, immune functions, viral/host interactions, angiogenesis, and cell growth in CLD and HCC, and proposes future research directions.

LIVER INTERNATIONAL (2023)

Article Gastroenterology & Hepatology

Evaluation of the HBV liver reservoir with fine needle aspirates

Barbara Testoni, Armando Andres Roca Suarez, Arianna Battisti, Marie-Laure Plissonnier, Marintha Heil, Thierry Fontanges, Francois Villeret, Yasmina Chouik, Massimo Levrero, Upkar Gill, Patrick Kennedy, Fabien Zoulim

Summary: This study validated the possibility to quantify cccDNA and assess its transcriptional activity in patients with chronic hepatitis B by combining FNA and droplet digital PCR. The use of FNA in clinical trials to evaluate the intrahepatic viral reservoir during the development of new antivirals and immunomodulatory agents is supported.

JHEP REPORTS (2023)

Article Gastroenterology & Hepatology

Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)

Fabienne Marcellin, Sylvie Bregigeon-Ronot, Clemence Ramier, Camelia Protopopescu, Camille Gilbert, Vincent Di Beo, Claudine Duvivier, Morgane Bureau-Stoltmann, Eric Rosenthal, Linda Wittkop, Dominique Salmon-Ceron, Patrizia Carrieri, Philippe Sogni, Tangui Barre

Summary: This study aimed to investigate the prevalence of moderate-to-severe depression in people living with HIV and HCV after successful HCV treatment, and identify associated socio-behavioral factors. Through descriptive and logistic regression analyses of data from 398 participants, it was found that 23.9% of HCV-cured individuals had moderate-to-severe depression. Female sex, unhealthy alcohol use, sedentary lifestyle, and unhealthy eating behaviors were associated with increased odds of moderate-to-severe depression.

JHEP REPORTS (2023)

Article Surgery

Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation

Paolo Angelo Cortesi, Raffaella Vigano, Sara Conti, Ilaria Lenci, Riccardo Volpes, Silvia Martini, Mario Angelico, James Fung, Maria Buti, Audrey Coilly, Francois Durand, Constantino Fondevila, Pascal Lebray, Frederik Nevens, Wojciech G. Polak, Mario Rizzetto, Fabien Zoulim, Giovanni Perricone, Marina Berenguer, Lorenzo Giovanni Mantovani, Christophe Duvoux, Luca Saverio Belli

Summary: The European Liver and Intestine Transplant Association (ELITA) held a Consensus Conference involving experts worldwide to update guidelines on HBV prophylaxis in liver transplant candidates and recipients. A simulation model was developed to compare the economic impact of implementing the new ELITA guidelines. The model showed that the guidelines could save around euro 235.65 million after 5 years and euro 540.73 million after 10 years. These savings could be used to allocate resources to different needs.

TRANSPLANT INTERNATIONAL (2023)

Article Gastroenterology & Hepatology

Spatial transcriptomics reveals a low extent of transcriptionally active hepatitis B virus integration in patients with HBsAg loss

Xiaoqi Yu, Qiming Gong, Demin Yu, Yongyan Chen, Ying Jing, Fabien Zoulim, Xinxin Zhang

Summary: Active HBV integration events are present in the liver tissue of patients with chronic HBV infection, including those with HBsAg loss. Antiviral treatment can decrease the number and extent of transcriptionally active viral integrations, suggesting that early treatment intervention may further reduce the risk of HBV infection.
Article Respiratory System

DIAGNOSTIC VALUE OF ELEVATED SERUM ANGIOTENSIN-CONVERTING ENZYME AND LYMPHOPENIA IN PATIENTS WITH GRANULOMATOUS HEPATITIS

Thomas El Jammal, Francois Dhelft, Pierre Pradat, Francois Bailly, Fabien Zoulim, Arnaud Hot, Maxime Fauter, Ayoub Drissi-Bakhkhat, Isabelle Durieu, Jean-Christophe Lega, Yvan Jamilloux, Pascal Seve

Summary: This study suggests that lymphopenia and sACE may be valuable biomarkers for sarcoidosis diagnosis in patients with granulomatous hepatitis when combined, especially in younger patients.

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES (2023)

No Data Available